尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Roberts Zachary. Insider active across 2 companies, notably Allogene Therapeutics, Inc.. Cumulatively, 9 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €166k. History available since 20 January 2023. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Roberts Zachary is a declarant linked to Allogene Therapeutics, Inc. on XNAS, where he holds the role of EVP of R&D. He has 9 filings in total, and in the recent filings observed between 2023-01-24 and 2026-02-04, sales total 165970 EUR and the modal transaction nature is Cession.